XTALPI SUBMITS U.S. FDA IND APPLICATION FOR KQTD-126, A POTENTIAL FIRST-IN-CLASS, GUT-RESTRICTED PAN-TRK INHIBITOR FOR CHRONIC INTESTINAL PAIN

Reuters · 2d ago

Please log in to view news